Drugs / YIV-906
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04000737 | Jan 2020 → Mar 2024 | hepatocellular carcinoma | Yiviva Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YIV-906 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04000737 ↗ |
| Route | Oral | “YIV-906 is a botanical drug candidate, composed of an extract of four herbs and administered in oral capsule form.” NCT04000737 ↗ |